-
???insights.card.a11y.category??? news News
Mizuho’s Jared Holz on finding opportunities in the biotech space
-
???insights.card.a11y.category??? news News
Eli Lilly and Novo Nordisk will remain leaders in the weight-loss drug market: Mizuho’s Jared Holz
-
???insights.card.a11y.category??? news News
Introducing the Mizuho Corporate Culture Award
-
???insights.card.a11y.category??? news News
Baidu’s latest results are ‘very respectable,’ analyst says
-
???insights.card.a11y.category??? news News
Zealand’s obesity drug shouldn’t disrupt Novo Nordisk-Eli Lilly leadership: Mizuho’s Jared Holz
-
???insights.card.a11y.category??? news News
Capital One and Discover merger could pose risks to Visa and Mastercard, says Dan Dolev
-
???insights.card.a11y.category??? news News
Coinbase rally is setting itself up for a bigger fall when it reports, says Mizuho’s Dan Dolev
-
???insights.card.a11y.category??? news News
Amgen has ‘a lot to prove’ in the weight-loss drug category, says Mizuho’s Jared Holz
-
???insights.card.a11y.category??? news News
Health care’s underperformance last year sets it up well for 2024, says Mara Goldstein